Abstract:Abstract BACKGROUND AND AIMS Haemodialysis patients are known to be susceptible to a wide range of early and long-term complications such as chronic inflammation, infections, malnutrition, mineral bone disorders (CKD-MBD) and cardiovascular disease that significantly affect the incidence of mortality.The aim of this study is to assess the presence of traditional risk factors for mortality such as diabetes mellitus or cardiovascular disease on one hand and non-traditional risk factors on the other hand (chronic inflammation, CKD-MBD). METHOD We conducted a single-centre study that included 63 CKD G5D patients (haemodialysis for 1–5 years) followed up for 48 months. All patients have been assessed at baseline, regarding cardiovascular disease (medical history, echocardiography and ECG), we performed using standard methods blood biochemistry, complete blood count and markers of inflammation (CRP, IL-6) and markers of CKD-MBD (sKlotho, iPTH, serum calcium and serum phosphorus). RESULTS After 24 months of follow-up, we found a mortality rate of 22.23%, while after 48 months, the mortality rate was of 50.73%. Baseline plasma IL-6 levels showed a strong statistically significant correlation with sKlotho (r = 0.57, P = 0.001), but no statistically significant correlation with other elements of CKD-MBD was present (serum calcium, serum phosphorus and iPTH). sKlotho showed a positive correlation with haemodialysis efficiency (eKTV) (r = 0.26, P = 0.04)., Decreased levels of sKlotho at baseline correlated significantly with the presence of signs of ischaemia on ECG (190.3 versus 381.57 pg/mL; P = 0.028). Inflammation markers (IL-6 and CRP) showed no statistically significant correlation with any of the markers of cardiovascular disease (presence of vascular calcifications and of left ventricular hypertrophy). The level of iPTH at baseline was significantly lower in the group of patients that survived the following 4 years of haemodialysis (428.08 ± 315.39 versus 666.76 ± 484.55 pg/mL, P = 0.029). In a Cox proportion-hazards regression analysis of predicting factors of mortality, only age and not inflammation markers (IL-6 and CRP) showed a statistically significant correlation with 4-year mortality (P = 0.032). Patients with higher levels of sKlotho showed a decreased risk of mortality, however not statistically significant. We found a higher risk of all-cause mortality after 24 months in patients with diabetes mellitus [OR 6.9, 95% confidence interval (95% CI) 1.6924–28.1469; P = 0.007], and after 48 months in patients with a history of cerebro-vascular disease (OR 21.8571, 95% CI 1.2018–397.5026; P = 0.0371) and with left ventricular hypertrophy (OR 2.7259, 95% CI 0.9596–7.7437; P = 0.0598). CONCLUSION In our study, although the inflammation marker IL-6 showed correlations with features of CKD-MBD, it did not lead to an increased mortality, which was influenced rather by traditional risk factors such as age, diabetes mellitus or history of cardiovascular disease, but also by CKD-MBD (iPTH).

The Relationship between Circulating Kidney Injury Molecule-1 and Cardiovascular Morbidity and Mortality in Hemodialysis Patients

Predicting Cardiovascular Mortality in Chronic Kidney Disease (CKD) Patients.

Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease

MO933: are Chronic Inflammation and CKD-MBD Risk Factors of Mortality in Hemodialysis Patients?

Blood Kidney Injury Molecule-1 is a Biomarker of Acute and Chronic Kidney Injury and Predicts Progression to ESRD in Type I Diabetes.

Kidney Injury Molecule-1 Levels Are Associated with Therapeutic Outcomes and Renal Tubulointerstitial Injury Severity in Idiopathic Membranous Nephropathy

Plasma kidney injury molecule-1 (p-KIM-1) levels and deterioration of kidney function over 16 years

Novel Biomarkers in Evaluating Cardiac Function in Patients on Hemodialysis—A Pilot Prospective Observational Cohort Study

Kidney Injury Molecule-1 Level is Associated with the Severity of Renal Interstitial Injury and Prognosis in Adult Henoch–Schönlein Purpura Nephritis

Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD

High Urinary Excretion of Kidney Injury Molecule-1 Predicts Adverse Outcomes in Acute Kidney Injury: a Case Control Study

Urinary Biomarkers of Kidney Tubule Health and Mortality in Persons with CKD and Diabetes Mellitus

Diagnostic Value Of Urinary Kidney Injury Molecule 1 For Acute Kidney Injury: A Meta-Analysis

Elevated Serum KIM-1 in Sepsis Correlates with Kidney Dysfunction and the Severity of Multi-Organ Critical Illness

Circulating Vascular Adhesion Protein-1 Level Predicts the Risk of Cardiovascular Events and Mortality in Hemodialysis Patients

Kidney injury molecule-1 expression predicts structural damage and outcome in histological acute tubular injury

Plasma Creatine Kinase and All-Cause Mortality in Patients on Peritoneal Dialysis: a Multi-Center Retrospective Study

Does serum kidney injury molecule-1 predict early diabetic nephropathy: A comparative study with microalbuminuria

Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial

Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity.

Value of Serum Kidney Injury Molecule-1 in Early Prediction of Kidney Injury in Patient with Ascites and Spontaneous Bacterial Peritonitis